Rankings
▼
Calendar
NAGE Q4 2015 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$392M
Q4 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
Gross Profit
$2M
36.7% margin
Operating Income
-$1M
-28.4% margin
Net Income
-$1M
-32.7% margin
EPS (Diluted)
$-0.04
Cash Flow
Operating Cash Flow
-$853,576
Free Cash Flow
-$1M
Stock-Based Comp.
$321,107
Balance Sheet
Total Assets
$19M
Total Liabilities
$13M
Stockholders' Equity
$5M
Cash & Equivalents
$6M
← FY 2015
All Quarters
Q1 2016 →
